Safety issues in magnetic resonance imaging

Journal of Neuro-Ophthalmology

Volumn 22, Issue 1, 2002, Pages 35-39

  Chung, Sophia M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERIC ACID; GADOTERIDOL; MANGAFODIPIR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE;

CLAUSTROPHOBIA; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SAFETY; HEARING LOSS; HUMAN; IMPLANT; MAGNETIC FIELD; NEPHROTOXICITY; NEUROOPHTHALMOLOGY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; REVIEW; SAFETY; SEDATION;

EID: 0036216936     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041327-200203000-00009     Document Type: Review

References (61)

1. Human exposure to 4.0-Tesla magnetic fields in a whole-body scanner
2. Human magnetic resonance imaging at 8.0 T
3. Influence of strong magnetic fields on the electrocardiograph of squirrel monkeys (Saimiri sciureus)
4. The AAPM/RSNA physics tutorial for residents: MR imaging safety considerations
5. High-field-strength MR imaging and metallic biomedical implants: An ex vivo evaluation of deflection forces
6. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers
7. MR procedures and patients with electrically, magnetically, and mechanically activated implants and devices
8. Potential hazards and artifacts of ferromagnetic and nonferromagnetic surgical and dental materials and devices in nuclear magnetic resonance imaging
9. Magnetic resonance imaging and surgical clips
10. MR imaging after surgery for vertebrobasilar aneurysm
11. Safety of MR scanning in patients with nonferromagnetic aneurysm clips
12. Aneurysm clips
13. Aneurysm clip motion during magnetic resonance imaging: In vivo experimental study with metallurgical factor analysis
14. Comparison of MR imaging and CT in patients with intracranial aneurysm clips
15. MR imaging of metallic implants and materials: A compilation of the literature
16. Aneurysm clips: Effects of long-term and multiple exposures to a 1.5-T MR system
17. Yasargil aneurysm clips: Evaluation of interactions with a 1.5-T MR system
18. Placement of a ferromagnetic intracerebral aneurysm clip in a magnetic field with a fatal outcome
19. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils
20. Ferromagnetism of intraocular foreign body causes unilateral blindness after MR study
21. Magnetic resonance imaging of prosthetic heart valves
22. Effect of magnetic resonance imaging on a new electromagnetic implantable middle ear hearing device
23. Policies, guidelines, and recommendations for MR imaging safety and patient management
24. Sensory stimulation by time-varying magnetic fields
25. Magnetochemical stress in the human retina and the safety of MR imaging
26. Unusual burns of the lower extremities caused by a closed conducting loop in a patient at MR imaging
27. Severe burns resulting from magnetic resonance imaging with cardiopulmonary monitoring. Risks and relevant safety precautions
28. Tattoo-induced skin burn during MR imaging
29. Magnetic resonance imaging of postoperative patients with metallic in plants
30. Effect of magnetic resonance imaging on implantable eyelid weights
31. Hazards of magnetic resonance imaging
32. The effect of magnetic resonance imagers on implanted neurostimulators
33. MR imaging of patients with implanted drug infusion pumps
34. Magnetic resonance imaging and cochlear implants: Compatibility and safety aspects
35. Biodistribution and toxicity of MR imaging contrast media
36. Safety of approved MR contrast media for intravenous injection
37. Safety of Magn Reson imaging contrast agents
38. Renal lesion characterization with gadolinium-enhanced MR imaging: Efficacy and safety in patients with renal insufficiency
39. Safety of ProHance in special populations
40. The dialyzability of gadolinium-DTPA
41. Magnetic resonance contrast agents for neuroimaging. Safety issues
42. Tolerance data of Gd-DTPA: A review
43. Clinical safety of gadopentetate dimeglumine
44. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat
45. The effect of Gd-dimeglumine on subcutaneous tissues: A study with rats
46. Gd-DTPA as an alternative contrast agent in conventional and interventional radiology
47. Bioeffects and safety
48. Induced alignment of flowing sickle erythrocytes in a magnetic field
49. Preservation of sickle cell blood flow patterns during MR imaging: An in vivo study
50. Magnetic resonance procedures and pregnancy
51. Infants exposed to MRI in utero have a normal paediatric assessment at 9 months of age
52. Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent
53. Survey of reproductive health among female MR workers
54. Anxiety in patients undergoing magnetic resonance imaging
55. Emotional distress during magnetic resonance imaging
56. Claustrophobia during MR imaging
57. Potential hearing loss resulting from MR imaging
58. MRI clinical site safety survey: Phase I results and preliminary data
59. Safety considerations in MR imaging
60. Reduction of sound levels with antinoise in MR imaging